Corporate Profile for Women's Capital Corporation, dated May 17, 2002.Business Editors --(BUSINESS WIRE) The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.
Published Date: May 17, 2002
Company Name: Women's Capital Corporation
Address: 1990 M Street, NW, Suite 250
Washington DC, 20036
USA
Main Telephone
Number: 800/330-1271
Internet Home
Page Address
(URL) www.go2planB.com
Chief Executive
Officer: Sharon Camp
Chief Financial
Officer: James Borger
Public Relations
Contact: Pam Long
E-mail address: pam.long@bh.ny.ddb.com
Industry: Healthcare
Company description: The Women's Capital Corporation (WCC WCC n abbr (= World Council of Churches) → COE m (Conseil œcuménique des Églises) WCC n abbr (= World Council of Churches) → Weltkirchenrat m ) is a Washington, DC-based, privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. , organized in January 1997, to bring Plan B to the U.S. and Canadian markets, and to develop and market reproductive health Within the framework of WHO's definition of health[1] as a state of complete physical, mental and social well-being, and not merely the absence of disease or infirmity, reproductive health, or sexual health/hygiene products of critical importance to women. WCC's efforts to develop and market Plan B represent a novel public/private sector partnership. Plan B is the first progestin-only pill developed to prevent pregnancy after a contraceptive contraceptive /con·tra·cep·tive/ (-sep´tiv) 1. diminishing the likelihood of or preventing conception. 2. an agent that so acts. accident or unprotected sex Unprotected sex refers to any act of sexual intercourse in which the participants use no form of barrier contraception. Sexually transmitted infections Specifically, unprotected sex . WCC's mission is to provide a home for important reproductive health technologies orphaned by the major pharmaceutical companies. The company seeks to acquire products that are already in relatively advanced stages of development in government or non-profit national or international research institutions or which are available for licensing from national and multinational pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. . |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion